Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer. by Generali, D, Buffa, F, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Papotti, M, Dogliotti, L, Bottini, A, Harris, A, Fox, S

Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. by Hubina, E, Nanzer, A, Hanson, MR, Ciccarelli, E, Losa, M, Gaia, D, Papotti, M, Terreni, MR, Khalaf, S, Jordan, S, Czirják, S, Hanzély, Z, Nagy, G, Góth, M, Grossman, AB, Korbonits, M